Recurrent Gastrointestinal Stromal Tumors in the Imatinib Mesylate Era: Treatment Strategies for an Incurable Disease.
Rebecca M PlatoffWilliam F MoranoLuiz MarconciniNicholas DeLeoBeth L MapowMichael StylerWilbur B BownePublished in: Case reports in oncological medicine (2017)
Current strategies to treat recurrent GIST include dose escalation, modifying adjuvant tyrosine kinase inhibitor therapy, and surgery. High-level evidence will be required to better define the combinatory roles of tyrosine kinase inhibitor therapy, guided by molecular profiling, and surgery in the management of recurrent GIST.